跳至主要内容
临床试验/RBR-3wmd9s
RBR-3wmd9s进行中(未招募)未知

Vitrectomy with or without phacoemulsification for treatment of Macular Hole and Epiretinal membrane

Hospital das Clínicas de Ribeirão Preto0 个研究点开始时间: 2018年8月31日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
20Y 至 90Y(—)

入选标准

  • Patients with a diagnosis of idiopathic macular hole;epiretinal membrane with indication of vitrectomy surgery;Patients without cataract or with opacification of crystalline at most 2 + / 6 + cortical and 2 + / 6 + nuclear, without SCP opacity

排除标准

  • another eye disease;Any previous ocular surgery, with the exception of intravitreal injections;Systemic disorders affecting the eye;Inability to report satisfactorily or inability to collaborate, preventing us from obtaining well-documented examinations; Crystalline opacity that interferes with the visualization of the vitreous chamber, that is, posterior subcapsular of any intensity and nuclear or cortical greater or equal to 3+.

研究者

发起方
Hospital das Clínicas de Ribeirão Preto

相似试验